Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 11,272 shares at $154.95 ($1.8M) on 2018-03-16, disclosed to the SEC on 2018-03-20.
Open-market sale of $1.8M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.95 | 1,000 | $155K | 8.7% |
| 2 | $156.75 | 2,208 | $346K | 19.5% |
| 3 | $157.41 | 7,264 | $1.1M | 64.6% |
| 4 | $157.98 | 400 | $63K | 3.6% |
| 5 | $157.98 | 400 | $63K | 3.6% |
| Total | $157.10 avg | 11,272 |
| $1.8M |
| 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |